AIM
$1.44
Aim Immunotech
$.06
4.35%
AIM
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Feb 15
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when AIM reports earnings?
Beat
Meet
Miss

Where is AIM's stock price going from here?
Up
Flat
Down
Stock chart of AIM
Analysts
Summary of analysts' recommendations for AIM
Score
Grade
Pivots
Resistance
$1.61
$1.55
$1.49

$1.43

Support
$1.37
$1.31
$1.25
Tweet
Growth
Description
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.